ArticleOncoTargets and therapy2022

Survivin Splice Variant 2β Enhances Pancreatic Ductal Adenocarcinoma Resistance to Gemcitabine.

Ryan N Fuller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.